ArticleJournal of Cancer2026

Bevacizumab or Aflibercept in Combination with Second-Line FOLFIRI after Progression on FOLFOX Plus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Study.

Okan Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.